Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer.

about

Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer.

Item

http://www.wikidata.org/entity/Q53074949

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@en

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@nl

type

Item

label

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@en

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@nl

prefLabel

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@en

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@nl

P1476

Analysis of reduced-dose admin ...... therapy for colorectal cancer.

@en

P2093

Dawon Park

http://www.w3.org/2001/XMLSchema#string

Jin Kim

http://www.w3.org/2001/XMLSchema#string

Jung-Myun Kwak

http://www.w3.org/2001/XMLSchema#string

Seon-Hahn Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.

Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Efficacy of oxaliplatin in the treatment of colorectal cancer.

Oxaliplatin: a review in the era of molecularly targeted therapy

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Chemotherapy in colorectal cancer: new options and new challenges.

P304

196-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4174/ASTR.2018.94.4.196

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Se-Jin Baek

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29629354

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5880977

http://www.w3.org/2001/XMLSchema#string